Dr. Thomas Durcan is an Associate Professor and Director of the Early Drug Discovery Unit at the Montreal Neurological Institute. He oversees a team of 40+ research staff and students, committed to applying patient-derived stem cells towards the development of phenotypic discovery assays and 3D neuronal organoid models for neurodegenerative and neurodevelopmental disorders. He talks about modeling sporadic ALS in a dish, partnering with the Michael J. Fox Foundation, and promoting open science.
Featured Products and Resources:
- See the Stem Cell Podcast live at the New York Stem Cell Foundation!
- Learn about the STEMdiff™ Cerebral Organoid Kit from STEMCELL Technologies
The Stem Cell Science Round Up
SARS-CoV-2 in the Placenta – Researchers developed induced trophoblast stem cell models to study placental models of infection.
Hematopoietic Stem and Progenitor Cells in the Embryo – Loss of microRNA-128 in zebrafish leads to an expansion of hematopoietic stem and progenitor cells in the aorta–gonad–mesonephros.
Cochlear Organoids – Derived hair cells exhibit cochlear-like structural and functional properties.
Cell Replacement in a Chimeric Mouse Brain – Old or diseased human glial cells in the chimeric mouse brain are eliminated by transplanted young cells.
Photo Reference: Courtesy of Dr. Thomas Durcan